Background: Using peak expiratory flow (PEF) as an alternative to spirometry parameters (FEV1 and FVC), for detection of airway reversibility in diseases with airflow limitation is challenging. We developed logistic regression (LR) model to discriminate bronchodilator responsiveness (BDR) and then compared the results of models with a performance of >18%, >20%, and >22% increase in ΔPEF% (PEF change relative to baseline), as a predictor for bronchodilator responsiveness (BDR). Materials and Methods: PEF measurements of pre-bronchodilator, postbronchodilator and ΔPEF% of 90 patients with asthma (44) and chronic obstructive pulmonary disease (46) were used as inputs of model and the output was presence or absence of the BDR. Results: Although ΔPEF% was a poor discriminator, LR model could improve the accuracy of BDR. Sensitivity, specificity, positive predictive value, and negative predictive value of LR were 68.89%, 67.27%, 71.43%, and 78.72%, respectively.
alternative for spirometry and meets those criteria (3, 4, (18) (19) (20) .
Since bronchodilator response in asthmatic patients occurs first in large airways and to a lesser extent with delay in small airways, PEF may have some correlations with FEV1 after bronchodilator administration. Although there is evidence regarding the correlation of PEF and spirometry parameters (16, 17) , there are controversies in previous findings and this correlation is questioned in airway limitation (9, 15) . We need more accurate evidence regarding validity of measuring peak flow to assess airflow limitation and reversibility in asthmatics or COPD patients.
The aim of this study was to evaluate the efficacy of PEF measurement as an alternative to spirometry in predicting airway reversibility and developing logistic regression (LR) model, based on PEF values, to predict BDR in patients with asthma and COPD.
MATERIALS AND METHODS
Our prospective study was carried out from September 2010 to May 2011 in a teaching hospital. After the approval of institutional review board and ethics committee (Tehran University) an informed consent was obtained from patients. We prospectively studied patients with asthma and COPD. All examinations were done by the same pulmonologist to keep the diagnosis reliable and prevent variations according to ATS criteria (21) . After doing examinations and taking history, patients with the following criteria were excluded from the study: other pulmonary diseases, upper respiratory tract infection in the previous six weeks, cardiac or brain infarction in the previous one month, aortic, abdominal or brain aneurism, dementia, abdominal or thoracic surgery, and occupational exposure. Moreover, Short acting bronchodilator medications had to be discontinued 8 hours and long acting bronchodilators, corticosteroids and theophylline had to be withheld 48 hours prior to lung function tests.
Additionally, patients had to avoid smoking 1 hour, food intake 4 hours, exercise 1 hour and food or drinks that have caffeine or alcohol 4 hours before the tests. Performance of >18, >20, and >22 increase in ΔPEF% in subjects correctly identified with airway reversibility was assessed. All recordings were verified by the referrer pulmonologist. 
RESULTS
Of the 133 participants in this Study, 43 subjects were excluded because they did not meet ATS acceptability and reproducibility criteria. Data from 90 subjects (44 asthmatics and 46 COPD patients) were analyzed. The mean age of patients was 47.3±12.4 years (range 20-69 yrs).
Gender distribution was 63% males and 37% females, 23.4% of patients reported being active smokers, 23.3%
reported being former smokers (quitted more than a year ago), and 53.3% mentioned that they never smoked. BDR was documented by standard spirometric criteria in 55 Table1 shows the performance indices of ∆PEF% and LR in predicting BDR, compared to the standard spirometric criteria. ΔPEF% was a poor discriminator for estimating BDR. In contrast, the LR model could improve the accuracy of BDR. Since accuracy of ∆PEF%>20 for estimating airway reversibility was better than the other two cut-off values (>18 and >22 increase in ∆PEF%), we used ∆PEF%>20 for data analysis. In this research, BDR (>12% increase in FEV1 or FVC) was detected using a >20% increase in ΔPEF% with a sensitivity, specificity, PPV and NPV of 60%, 68.57%, 75%, and 52.17%, respectively. The real time use of the LR is not difficult. The number of hospitals that have an electronic medical record is increasing rapidly. Once trained, the LR could reside in the background of the clinical information systems. The data used by our LR is the standard information routinely collected from the patients. Once entered into the electronic record, these data could then be used by the LR to generate the probability of the predicted outcome. LR accuracy can be continuously improved over time because it can constantly be retrained as more patients are added to the system (23, 30).
Some limitations to this study need to be addressed. Secondly, this study was carried out at a single institution.
These findings must be corroborated on patients from multiple locations.
CONCLUSION
Our results indicated that ΔPEF% is a poor discriminator of BDR. However, the LR model could improve the accuracy of BDR finding using PEF values, and can be used clinically as an inexpensive and rapid method.
